Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
94%
OVERLAP
BY WEIGHT
36
# OF OVERLAPPING
HOLDINGS
ESIH.L
48
HOLDINGS
100%
ALSO IN EXV4.DE
EXV4.DE
60
HOLDINGS
80%
ALSO IN ESIH.L
SECTOR DRIFT (ESIH.L minus EXV4.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ESIH.L |
Weight in EXV4.DE |
Overlap | |
|---|---|---|---|---|
| ROCHE HOLDING AG-BR | 16.5% | 15.1% | 15.1% | |
| ASTRAZENECA PLC | 14.3% | 13.8% | 13.8% | |
| NOVARTIS AG | 14.1% | 13.7% | 13.7% | |
| NOVO NORDISK A/S-B | 9.7% | 9.3% | 9.3% | |
| SANOFI-AVENTIS | 5.2% | 5.2% | 5.2% | |
ESIH.L Overweight Relative to EXV4.DE
| ROCHE HOLDING AG-BR | 1.3% | |
| ASTRAZENECA PLC | 0.5% | |
| NOVARTIS AG | 0.5% | |
| NOVO NORDISK A/S-B | 0.4% | |
| GSK PLC | 0.2% | |
| UCB SA | 0.1% | |
| BAYER AG | 0.1% | |
| ARGEN-X SE | 0.1% | |
| LONZA GROUP AG-REG | 0.1% | |
| FRESENIUS SE | 0.1% |
ESIH.L Underweight Relative to EXV4.DE
| NOVOZYMES A/S-B SHARES | -1.1% | |
| CONVATEC GROUP PLC | -0.3% | |
| GETINGE AB-B SHS | -0.2% | |
| ZEALAND PHARMA A/S | -0.2% | |
| CAMURUS AB | -0.2% | |
| TECAN GROUP AG-REG | -0.1% | |
| AMBU A/S CLASS B | -0.1% | |
| BAVARIAN NORDIC A/S | -0.1% | |
| COLOPLAST A/S CLASS B | -0.1% | |
| AMPLIFON SPA | -0.1% |